Apotheek Versteele SRL
3.3 FTEThe score of Apotheek Versteele shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets +56 % Headcount (avg FTE) +154 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Versteele's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 31 Mar 2025
- Year ended 31 Dec 2023filed on 30 Apr 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
Apotheek Versteele's financial analysis
- Solvency69.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Versteele
Apotheek Versteele's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0472.673.377
- VAT number
- BE0472673377
- Peppol
- Registered · 0208:0472673377 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Sep 2000
- Registered office
- 8630 Veurne
- Size
- Micro · 3.3 FTE
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Versteele (SRL) has been based in Veurne since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 67,377 € and equity of 821,055 €; its revenue is not published. With 3.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 69.6%, above the median of its sector (44.2%).
Companies similar to Apotheek Versteele
Companies in the same business, of comparable size and area, outside its group.
- Brugafar Retail sale of pharmaceutical products Nieuwpoort · balance sheet €1.18m
- Pharmacie DU Baty Retail sale of pharmaceutical products Profondeville · balance sheet €1.18m
- Medigrex Retail sale of pharmaceutical products Wuustwezel · balance sheet €1.18m
- Apotheke Schunck Retail sale of pharmaceutical products Eupen · balance sheet €1.18m
- MPL Pharma Retail sale of pharmaceutical products Ciney · balance sheet €1.05m
- Pharmaphie SDW Retail sale of pharmaceutical products Ghent · balance sheet €1.19m
- Zellik Pharma Retail sale of pharmaceutical products Asse · balance sheet €1.25m
- Sanophar Retail sale of pharmaceutical products Menen · balance sheet €1.17m
Frequently asked questions about Apotheek Versteele
What is the revenue of Apotheek Versteele?
Apotheek Versteele files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Versteele?
In Belgium, the VAT number is the company number prefixed with BE: BE0472673377 for Apotheek Versteele, if the company is VAT-registered. Its company number (CBE) is 0472.673.377.
Where is the registered office of Apotheek Versteele?
According to the CBE register, the registered office of Apotheek Versteele is in 8630 Veurne.
What is the equity of Apotheek Versteele?
At the close of the 2025 financial year, the equity of Apotheek Versteele amounts to 821,055 €, a solvency of 69.6% of total assets.
How many people work at Apotheek Versteele?
3.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Versteele?
The register lists 3 active mandates at Apotheek Versteele. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Versteele
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →